Clinical trials
Terminated Phase 2 Non-alcoholic Fatty Liver Disease trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
42 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2003 | 1 |
| 2006 | 1 |
| 2007 | 2 |
| 2010 | 1 |
| 2011 | 1 |
| 2012 | 2 |
| 2013 | 3 |
| 2014 | 3 |
| 2015 | 1 |
| 2016 | 4 |
| 2017 | 4 |
| 2018 | 3 |
| 2019 | 8 |
| 2020 | 5 |
| 2021 | 1 |
| 2022 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Terminated | 42 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Novartis Pharmaceuticals | 4 |
| Gilead Sciences | 3 |
| Genfit | 2 |
| Zydus Therapeutics Inc. | 2 |
| Alexion Pharmaceuticals, Inc. | 1 |
| Antipodean Pharmaceuticals, Inc. | 1 |
| Bristol-Myers Squibb | 1 |
| Celgene | 1 |
| Corcept Therapeutics | 1 |
| Duke-NUS Graduate Medical School | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Non-alcoholic Fatty Liver Disease | 42 |
| Fatty Liver | 6 |
| Liver Cirrhosis | 4 |
| Liver Diseases | 3 |
| Diabetes Mellitus, Type 2 | 2 |
| Fibrosis | 2 |
| HIV Infections | 2 |
| Obesity | 2 |
| Ascites | 1 |
| Cholesterol Ester Storage Disease | 1 |
Trials
Showing 1 to 25 of 42. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.